The closing price of Ardelyx Inc (NASDAQ: ARDX) was $6.80 for the day, down -3.68% from the previous closing price of $7.06. On the day, 5544093 shares were traded.
Ratios:
Our analysis of ARDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on April 05, 2024, initiated with a Outperform rating and assigned the stock a target price of $14.
On December 18, 2023, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $12.
On September 07, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.H.C. Wainwright initiated its Buy rating on September 07, 2023, with a $9 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 01 ’24 when RAAB MICHAEL sold 1,518 shares for $7.31 per share. The transaction valued at 11,097 led to the insider holds 1,318,433 shares of the business.
GRAMMER ELIZABETH A sold 86,000 shares of ARDX for $664,978 on Mar 20 ’24. The insider now owns 312,993 shares after completing the transaction at $7.73 per share. On Feb 26 ’24, another insider, Rosenbaum David P., who serves as the Chief Development Officer of the company, sold 5,183 shares for $9.20 each. As a result, the insider received 47,684 and left with 175,936 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 12.71 while its Price-to-Book (P/B) ratio in mrq is 9.48.
Stock Price History:
Over the past 52 weeks, ARDX has reached a high of $10.13, while it has fallen to a 52-week low of $3.16.
Shares Statistics:
A total of 232.45M shares are outstanding, with a floating share count of 223.69M. Insiders hold about 3.87% of the company’s shares, while institutions hold 59.59% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by ARKX analysts. The consensus estimate for the next quarter is $6.80, with high estimates of $4.16 and low estimates of $376.26.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
